InvestorBrandNetwork
Bio
The InvestorBrandNetwork (IBN) is comprised of 40+ investor focused brands and offers a comprehensive suite of corporate communications solutions that reach new audiences on an ongoing focus basis. Full disclaimers: http://bit.ly/2S7w1sC
Stories (752/0)
HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF) Set for Leading Role in Cannabinoid Market Via Innovative Tech, New Tolling Contracts
Company is in late-stage negotiations to sign IPGrow™ hemp biomass tolling contracts with producers and hemp biomass providers in the U.S. and Canada for the 2020 hemp growing and production year U.S. sales of hemp-based cannabinoid products to reach $22 billion by 2022
By InvestorBrandNetwork4 years ago in Trader
SRAX Inc. (NASDAQ: SRAX) Rewards Social Media Users for Data as Other Platforms Lose Millions of Users in Privacy Backlash
SRAX enables users to earn compensation for sharing data, creates reliable data sets marketers can access Company recently partnered with Indian firm, facilitating entry into growing digital-ad market valued at $3.6 billion
By InvestorBrandNetwork4 years ago in Trader
Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Reaches Significant Milestones, Already Has Top-10 Product Two Months after New Market Entry
Plus Products cracks top-10 edibles product list within two months of expanding into Nevada market Company continues expansion by launching into the fast-growing national hemp CBD space
By InvestorBrandNetwork4 years ago in Trader
Sigma Labs Inc. (NASDAQ: SGLB) Software Aims to Bring Scalability, Profitability to EV 3D Metal Printing
EV production has begun using 3D printing to manufacture customized parts to overcome the limitations of traditional manufacturing SGLB is only known provider of software that addresses issues through real-time, in-process detection of irregularities and error reporting
By InvestorBrandNetwork4 years ago in Trader
ChineseInvestors.com Inc. (CIIX) CEO Looks to Increase Profits by Selling New Hemp-Based CBD Products in Untapped Chinese Market
CEO focused on profits in 2020; plans to create strategic B2B, B2C divisions CBD Biotech unaffected by changing CBD-product regulations due to company’s focus on hemp-based CBD cosmetics
By InvestorBrandNetwork4 years ago in Trader
Interpace Biosciences (NASDAQ: IDXG) Growth Capacity Aided by $20 Million Investment Agreement with Major Capital Partners
Company’s business units, Interpace Diagnostics and Interpace Pharma Solutions, support the biotech and pharmaceutical sectors as they seek to improve early cancer diagnosis and promote increasingly effective therapies Life sciences industry forecast to reach $33.2 billion by 2024, experiencing an 11.5% CAGR over 5-year period
By InvestorBrandNetwork4 years ago in Trader
No Borders Inc. (NBDR) Combines CBD Lab Test Data, Blockchain Security to Boost Consumer Confidence
No Borders cannabidiol (CBD) products can help people addicted to painkillers or suffering from poor sleep to improve their general wellbeing Blockchain applications developed through No Borders’ tech labs can help ensure the quality and legality of CBD products from test to shelf, and blockchain’s worth is becoming more evident as government agencies experiment with its data-tracking capabilities
By InvestorBrandNetwork4 years ago in Trader
Sigma Labs Inc. (NASDAQ: SGLB) Delivers Proprietary Technology to Solve Quality, Reliability Challenges in 3D Metal-Printing
Sigma Labs allows companies to build, qualify, and certify parts more quickly and at lower cost Before Sigma, no quality metric existed for melt pool monitoring, in situ monitoring, or process quality control that provided in process alerts and solutions
By InvestorBrandNetwork4 years ago in Trader
Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Inks Licensing Deal with Smokeless Cannadips CBD Product Maker
Inhalation is a particularly popular method of using tobacco and cannabis products, despite government warnings about the scientifically established dangers of doing so Lexaria has been boosting its profile and revenue potential through licensing agreements with other companies Lexaria recently announced a licensing agreement with Cannadips CBD-maker The Boldt Runners Corporation The agreement grants Cannadips CBD use of Lexaria’s DehydraTECH IP to improve the speed of its effectiveness and to combat the throat irritation that can accompany use of terpene-rich multi spectrum oils
By InvestorBrandNetwork4 years ago in Trader
Sigma Labs Inc. (NASDAQ: SGLB) to Capitalize on Growth of Large-Scale 3D Printing in 2020
SGLB’s revolutionary quality-assurance software offers unique solution to industry’s most significant hurdles to mass production Sigma Labs set to reap lucrative benefits of revolutionary technology that enables 3D metal printing industry to scale production
By InvestorBrandNetwork4 years ago in Trader